India
· Delayed Price · Currency is INR Eris Lifesciences Statistics
Total Valuation
BOM:540596 has a market cap or net worth of INR 229.44 billion. The enterprise value is 256.34 billion.
| Market Cap | 229.44B |
| Enterprise Value | 256.34B |
Important Dates
The last earnings date was Monday, August 4, 2025.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | Feb 13, 2025 |
Share Statistics
| Current Share Class | 136.21M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 40.86M |
Valuation Ratios
The trailing PE ratio is 59.36 and the forward PE ratio is 38.40.
| PE Ratio | 59.36 |
| Forward PE | 38.40 |
| PS Ratio | 7.82 |
| PB Ratio | 7.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 66.32 |
| EV / Sales | 8.73 |
| EV / EBITDA | 23.70 |
| EV / EBIT | 34.85 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 2.29 |
| Debt / FCF | n/a |
| Interest Coverage | 3.35 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.81% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 8.75M |
| Profits Per Employee | 1.15M |
| Employee Count | 3,354 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:540596 has paid 1.24 billion in taxes.
| Income Tax | 1.24B |
| Effective Tax Rate | 23.24% |
Stock Price Statistics
The stock price has increased by +40.73% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +40.73% |
| 50-Day Moving Average | 1,728.72 |
| 200-Day Moving Average | 1,457.79 |
| Relative Strength Index (RSI) | 41.04 |
| Average Volume (20 Days) | 5,497 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:540596 had revenue of INR 29.35 billion and earned 3.87 billion in profits. Earnings per share was 28.36.
| Revenue | 29.35B |
| Gross Profit | 21.98B |
| Operating Income | 7.35B |
| Pretax Income | 5.34B |
| Net Income | 3.87B |
| EBITDA | 10.70B |
| EBIT | 7.35B |
| Earnings Per Share (EPS) | 28.36 |
Balance Sheet
The company has 2.05 billion in cash and 24.78 billion in debt, giving a net cash position of -22.72 billion.
| Cash & Cash Equivalents | 2.05B |
| Total Debt | 24.78B |
| Net Cash | -22.72B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 32.72B |
| Book Value Per Share | 209.63 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 74.88%, with operating and profit margins of 25.03% and 13.17%.
| Gross Margin | 74.88% |
| Operating Margin | 25.03% |
| Pretax Margin | 18.21% |
| Profit Margin | 13.17% |
| EBITDA Margin | 36.46% |
| EBIT Margin | 25.03% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 7.35, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 7.35 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | 0.38% |
| Earnings Yield | 1.68% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |